US2019112731A1PendingUtilityA1

Manufacturing gradient materials using magnetically-assisted electrospinning

Assignee: HOLLOWAY JULIANNEPriority: Oct 12, 2017Filed: Oct 12, 2018Published: Apr 18, 2019
Est. expiryOct 12, 2037(~11.2 yrs left)· nominal 20-yr term from priority
D01D 5/0092A61L 27/48B29C 70/16D01D 5/0015D04H 3/04D04H 3/016D04H 3/015A61L 2300/44A61L 2300/624A61L 27/04A61L 2430/06A61L 2400/12A61L 27/446D01F 1/10A61L 2430/02A61L 27/54D01D 5/0076D01D 5/0069
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Described are fibrous materials comprising a plurality of fibers having a longitudinal alignment gradient and/or a longitudinal composition gradient. Also described are methods of preparing the fibrous materials thereof and methods of treating organ or tissue damage with the fibrous materials.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A fibrous material comprising a plurality of polymer fibers, wherein the plurality of fibers has a longitudinal alignment gradient of more than 70% aligned to less than 35% aligned. 
     
     
         2 . The fibrous material of  claim 1 , wherein the fibrous material has a longitudinal composition gradient. 
     
     
         3 . The fibrous material of  claim 1 , wherein the plurality of polymer fibers comprises a polymer selected from the group consisting of hyaluronic acid, polyethylene oxide, polyglycolic acid, polylactic acid, PLGA, polyolefin, polyacrylonitrile, polyurethane, polycarbonate, polycaprolactone, polyvinyl alcohol, cellulose, silk, polyaniline, polystyrene, chitosan, nylon, and combinations thereof. 
     
     
         4 . The fibrous material of  claim 1 , wherein the polymer fiber comprises a metal nanoparticle. 
     
     
         5 . The fibrous material of  claim 1 , wherein the fibrous material comprises a biomolecule, a drug molecule or a combination thereof. 
     
     
         6 . The fibrous material of  claim 1 , wherein the plurality of fibers has an average diameter of less than 5 μm. 
     
     
         7 . The fibrous material of  claim 1 , wherein the plurality of polymer fibers comprises a first fiber and a second fiber. 
     
     
         8 . The fibrous material of  claim 8 , wherein the first fiber and/or the second fiber is present at about 0.1% to about 95% by weight. 
     
     
         9 . The fibrous material of  claim 8 , further comprising a third fiber. 
     
     
         10 . The fibrous material of  claim 1 , wherein the longitudinal composition gradient comprises a biomolecule, a drug molecule or a combination thereof. 
     
     
         11 . A method of preparing a fibrous material comprising a plurality of polymer fibers, the method comprising: electrospinning a polymer fiber onto a collector having a first portion and a second portion to provide a fibrous material of  claim 1 , wherein at least one portion of the collector comprises a magnetic field. 
     
     
         12 . The method of  claim 11 , wherein the magnetic field is created by at least one magnet. 
     
     
         13 . The method of  claim 11 , wherein the applied magnetic field is greater than or equal to 1 mT. 
     
     
         14 . The method of  claim 11 , wherein a first fiber and a second fiber are electrospun onto the collector. 
     
     
         15 . The method of  claim 14 , wherein the first fiber is electrospun onto the first portion of the collector and the second fiber is electrospun onto the second portion of the collector. 
     
     
         16 . The method of  claim 15 , further comprising electrospinning a third fiber onto the collector. 
     
     
         17 . The method of  claim 11 , further comprising photoconjugating a biomolecule to the fibrous material. 
     
     
         18 . The method of  claim 17 , wherein the biomolecule is photoconjugated to the fibrous material using UV light or visible light. 
     
     
         19 . The method of  claim 17 , further comprising using at least one photo-opaque mask to create at least one longitudinal gradient in the biomolecule conjugation. 
     
     
         20 . A method of treating organ or tissue damage in a subject, the method comprising introducing a fibrous material of  claim 1  into a subject in need thereof at or near the organ or tissue.

Join the waitlist — get patent alerts

Track US2019112731A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.